Predictors of calcification distribution in severe tricuspid aortic valve stenosis.
Kerstin PiaydaLisa DannenbergSaif ZakoOliver MaierGeorg BosbachAmin PolzinShazia AfzalChristian JungRalf WestenfeldMalte KelmTobias ZeusVerena VeulemansPublished in: The international journal of cardiovascular imaging (2021)
We investigated aortic valve calcification (AVC) distribution and predictors for leaflet calcification patterns in patients with severe tricuspid aortic valve stenosis undergoing transcatheter aortic valve replacement (TAVR). Patients undergoing routine multi-sliced computed tomography (MSCT) for procedural planning were enrolled. MSCT data were transferred to a dedicated workstation for evaluation (3mensio Structural Heart™, Pie Medical Imaging BV, Maastricht, The Netherlands) and analyzed. Participants were separated into asymmetrical (AC) and symmetrical (SC) leaflet calcification and potential predictors for calcification distribution were identified with univariate and multivariate regression analysis. 567 Participants with severe tricuspid AS were divided into asymmetrical (AC, n = 443; 78.1%) and symmetrical (SC, n = 124; 21.9%) AVC. In AC, the non-coronary cusp was the most calcified cusp (n = 238; 57.7%). SC is more common in females (AC/SC: 49.2% vs. 67.7%; p < 0.0001). AVC was more severe in patients with AC, who also have larger aortic root dimensions. Multivariate analysis depicted, inter alia, left ventricular outflow tract (LVOT) calcification < 25 Agatston units (OR 1.81 [1.09-3.00], p = 0.021), a mean pressure gradient < 36 mmHg (OR 1.77 [1.03-3.05], p = 0.039), and an annulo-apical angle > 67° (OR 1.68 [1.00-2.80], p = 0.049) as predictors for SC, although with only moderate predictive value. Data from this retrospective analysis indicate that SC occurs more frequently in females. The cumulative leaflet calcification burden is higher in patients with AC, who also present with larger aortic root dimensions. The predictive value for prominent calcification of different aortic valve cusps in AC patients was only low to moderate.Trial registration number: NCT01805739.
Keyphrases
- aortic valve
- transcatheter aortic valve replacement
- aortic stenosis
- chronic kidney disease
- aortic valve replacement
- transcatheter aortic valve implantation
- end stage renal disease
- computed tomography
- left ventricular
- early onset
- patients undergoing
- high resolution
- ejection fraction
- heart failure
- healthcare
- clinical trial
- acute myocardial infarction
- coronary artery
- mitral valve
- randomized controlled trial
- coronary artery disease
- big data
- inflammatory response
- climate change
- electronic health record
- lps induced
- lipopolysaccharide induced
- patient reported outcomes
- clinical practice
- single molecule
- acute coronary syndrome
- cardiac resynchronization therapy